LI Ling, ZHANG Chun-li, WANG Rong-fu. Design and Development on Tumor Imaging of Nonpeptide Small Molecular Antagonists of Integrin αⅤβ3[J]. Journal of Isotopes, 2010, 23(4): 247-252. DOI: 10.7538/tws.2010.23.04.0247
Citation: LI Ling, ZHANG Chun-li, WANG Rong-fu. Design and Development on Tumor Imaging of Nonpeptide Small Molecular Antagonists of Integrin αⅤβ3[J]. Journal of Isotopes, 2010, 23(4): 247-252. DOI: 10.7538/tws.2010.23.04.0247

Design and Development on Tumor Imaging of Nonpeptide Small Molecular Antagonists of Integrin αβ3

  • Integrin αβ3 is significant to tumor angiogenesis, which is necessary for tumor growth and metastasis. So, it’s beneficial for us to make noninvasive visualizations and targeted treatments in tumor patients to detect malignant tumors and inhabit tumor metastasis early by using radiolabeled integrin αβ3 antagonists which have high specificity and affinity to integrin αβ3. This article will focus on the current researches on nonpeptide small molecular antagonists of integrin αβ3 by computerassisted drug design(CADD) to review the nonpeptide antagonists of integrin αβ3 in present progress. Also, it makes an analysis on the applications of radiolabeled small molecular antagonists as probes in tumor imaging.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return